Serotonin–Cannabinoid Receptor Heteromers as Context-Dependent Targets in Mood Disorders

Antidepressant and mood-stabilizer pharmacology is still largely described in terms of occupancy at individual receptors, yet clinical response is heterogeneous across patients given identical compounds at identical doses. G protein-coupled receptor (GPCR) heteromerization offers one underused explanation. Within a heteromer, allosteric receptor–receptor interaction, cross-antagonism, redirected or biased signalling and altered trafficking make the functional consequence of occupying a receptor depend on which partner shares its membrane, so that occupancy underdetermines outcome. This review applies that principle to the serotonin–cannabinoid interface, which is of direct interest for mood disorders because both systems are targets of current and emerging treatments. The demonstrated complexes are cross-diagonal: CB1–5-HT2A, supported by bimolecular fluorescence complementation, bioluminescence resonance energy transfer (BRET), proximity ligation assay (PLA) and by disruption experiments in which abolishing the complex removes Δ9-tetrahydrocannabinol-induced cognitive impairment while sparing other drug effects; and CB2–5-HT1A, supported by BRET and PLA, modulated by cannabidiol, and the basis of a dual-agonist program for depression and anxiety. The widely assumed CB1–5-HT1A pairing has never been demonstrated as a physical complex. A parallel network of 5-HT1A heteroreceptor complexes in raphe–hippocampal circuits, and the 5-HT2A–mGluR2 complex that distinguishes hallucinogenic from antipsychotic signalling, together indicate that receptor context is a tractable variable for drug design, for patient stratification, and for the unresolved question of whether the subjective state produced by rapid-acting serotonergic agents is required for their antidepressant effect. Evidential strength is graded throughout, and a reproducibility ledger and research agenda are provided.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-12
DOI
https://doi.org/10.20944/preprints202611.1345.v1
Primary Topic
Cannabis and Cannabinoid Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Serotonin–Cannabinoid Receptor Heteromers as Context-Dependent Targets in Mood Disorders

Philippe Henry
Preprints.org
Cannabis and Cannabinoid Research
preprint

Serotonin–Cannabinoid Receptor Heteromers as Context-Dependent Targets in Mood Disorders

Philippe Henry
preprint en

Abstract

Antidepressant and mood-stabilizer pharmacology is still largely described in terms of occupancy at individual receptors, yet clinical response is heterogeneous across patients given identical compounds at identical doses. G protein-coupled receptor (GPCR) heteromerization offers one underused explanation. Within a heteromer, allosteric receptor–receptor interaction, cross-antagonism, redirected or biased signalling and altered trafficking make the functional consequence of occupying a receptor depend on which partner shares its membrane, so that occupancy underdetermines outcome. This review applies that principle to the serotonin–cannabinoid interface, which is of direct interest for mood disorders because both systems are targets of current and emerging treatments. The demonstrated complexes are cross-diagonal: CB1–5-HT2A, supported by bimolecular fluorescence complementation, bioluminescence resonance energy transfer (BRET), proximity ligation assay (PLA) and by disruption experiments in which abolishing the complex removes Δ9-tetrahydrocannabinol-induced cognitive impairment while sparing other drug effects; and CB2–5-HT1A, supported by BRET and PLA, modulated by cannabidiol, and the basis of a dual-agonist program for depression and anxiety. The widely assumed CB1–5-HT1A pairing has never been demonstrated as a physical complex. A parallel network of 5-HT1A heteroreceptor complexes in raphe–hippocampal circuits, and the 5-HT2A–mGluR2 complex that distinguishes hallucinogenic from antipsychotic signalling, together indicate that receptor context is a tractable variable for drug design, for patient stratification, and for the unresolved question of whether the subjective state produced by rapid-acting serotonergic agents is required for their antidepressant effect. Evidential strength is graded throughout, and a reproducibility ledger and research agenda are provided.

Preprints.org
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon